2022年国际靶向抗癌治疗大会ESMO TARGETED ANTICANCER THERAPIES CONGRESS 2022

2022年ESMO国际靶向抗癌治疗大会(TAT2022)将于2022年3月7-9日以虚拟会议形式举行，会议由欧洲肿瘤内科学会(ESMO)组织。靶向抗癌治疗(TAT)大会是ESMO官方年度会议，自2018年开始每年在欧洲举办。TAT会议是专注于讨论早期药物开发和转化研究的首要论坛，会议议题涵盖靶向药物、免疫肿瘤学和涉及此类药物的组合等方面。来自学术界和工业界的领导者、临床医生、研究人员和监管机构一起共同努力，加快开发新的抗癌治疗方法以提高患者的预后效果。

欧洲肿瘤内科学会（ESMO）成立于1975年，是全球领先的肿瘤内科学专业组织。ESMO是肿瘤学教育和信息的参考学会，现在全球160多个国家和地区拥有超过25,000余名会员；ESMO致力于通过宣促进多学科的癌症护理，支持肿瘤学家的专业发展以及在全球倡导可持续的癌症护理，尽而为癌症患者提供最佳的护理。

ESMO TARGETED ANTICANCER THERAPIES CONGRESS 2022
Date: 7 - 9 Mar 2022
Venue: Virtual

The home of Phase 1 in oncology

In light of the high number of COVID-19 cases and concerns about the new SARS-CoV-2 variant, ESMO has made the decision to hold the ESMO Targeted Anticancer Therapies Congress 2022 as a virtual event only, with no in-person participation in Paris.

The safety of our faculty and delegates remains our top priority at this difficult time.

We are confident that our virtual format will effectively disseminate the latest advances in phase I oncology trials and give experts from all around the world the chance to identify promising new research avenues.

ESMO TAT 2022, known as “The Home of Phase I in Oncology” will offer participants a glimpse of the future of targeted anticancer therapies, focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development.

Stakeholders from academia and industry will discuss with clinicians, researchers, and regulators the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.

摘要征集：

Abstract submission deadline

点此提交摘要>>>Submit Abstract>>>

摘要提交指南>>>ESMO TAT 2022 Abstract Regulations

Outcome notifications

Outcome notifications are expected to be made available to first authors by end-January 2022.

Abstract submission categories

• Immunotherapy
• Kinase-targeting agents and cell signalling modulators
• Antibody-based therapies
• Epigenetics
• DNA damage repair
• Miscellaneous

Presentation and publication of abstracts accepted for the TAT 2022

The TAT 2022 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster – Display sessions for review, discussion and questions. Presenting authors must be available for Q&A for one hour to represent their work.

All accepted abstracts will be published as a supplement to the official ESMO journal, Annals of Oncology.

Publication schedule for accepted abstracts

1. Abstracts accepted for presentation at TAT 2022 as Poster will be published online on the ESMO website at 12:00 CET on Thursday, 3 March 2022.
2. Abstracts accepted for presentation at TAT 2022 as Proffered Paper (oral presentation) and Mini Oral will be published online on the ESMO website at 12:00 CET on Monday, 7 March 2022.
3. The publication schedule of abstracts with a different release will be available 10 days before the Congress.

Travel Grants

A restricted number of travel grants to TAT 2022 are available, upon application, to first author (= presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the TAT 2022 Scientific Committee on a competitive basis from among the accepted abstracts.

ESMO TAT 2022 注册费